Effect of Influenza Vaccination on Risk of Coronavirus Disease 2019 : A Prospective Cohort Study of 46 000 Healthcare Workers
© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com..
BACKGROUND: The purpose of this study was to assess whether influenza vaccination has an impact on the risk of coronavirus disease 2019 (COVID-19).
METHODS: A cohort of 46 112 healthcare workers were tested for antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and filled in a survey on COVID-19 symptoms, hospitalization, and influenza vaccination.
RESULTS: The risk ratio of hospitalization due to SARS-CoV-2 for influenza vaccinated compared with unvaccinated participants was 1.00 for the seasonal vaccination in 2019/2020 (confidence interval, .56-1.78, P = 1.00). Likewise, no clinical effect of influenza vaccination on development of antibodies against SARS-CoV-2 was found.
CONCLUSIONS: The present findings indicate that influenza vaccination does not affect the risk of SARS-CoV-2 infection or COVID-19.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:226 |
---|---|
Enthalten in: |
The Journal of infectious diseases - 226(2022), 1 vom: 12. Aug., Seite 6-10 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kristensen, Jonas Henrik [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 15.08.2022 Date Revised 21.08.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.1093/infdis/jiac001 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM335251684 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM335251684 | ||
003 | DE-627 | ||
005 | 20231225225419.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/infdis/jiac001 |2 doi | |
028 | 5 | 2 | |a pubmed24n1117.xml |
035 | |a (DE-627)NLM335251684 | ||
035 | |a (NLM)34989811 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kristensen, Jonas Henrik |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effect of Influenza Vaccination on Risk of Coronavirus Disease 2019 |b A Prospective Cohort Study of 46 000 Healthcare Workers |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.08.2022 | ||
500 | |a Date Revised 21.08.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com. | ||
520 | |a BACKGROUND: The purpose of this study was to assess whether influenza vaccination has an impact on the risk of coronavirus disease 2019 (COVID-19) | ||
520 | |a METHODS: A cohort of 46 112 healthcare workers were tested for antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and filled in a survey on COVID-19 symptoms, hospitalization, and influenza vaccination | ||
520 | |a RESULTS: The risk ratio of hospitalization due to SARS-CoV-2 for influenza vaccinated compared with unvaccinated participants was 1.00 for the seasonal vaccination in 2019/2020 (confidence interval, .56-1.78, P = 1.00). Likewise, no clinical effect of influenza vaccination on development of antibodies against SARS-CoV-2 was found | ||
520 | |a CONCLUSIONS: The present findings indicate that influenza vaccination does not affect the risk of SARS-CoV-2 infection or COVID-19 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a cohort study | |
650 | 4 | |a healthcare workers | |
650 | 4 | |a influenza vaccination | |
700 | 1 | |a Bo Hasselbalch, Rasmus |e verfasserin |4 aut | |
700 | 1 | |a Pries-Heje, Mia |e verfasserin |4 aut | |
700 | 1 | |a Nielsen, Pernille Brok |e verfasserin |4 aut | |
700 | 1 | |a Dehlbæk Knudsen, Andreas |e verfasserin |4 aut | |
700 | 1 | |a Fogh, Kamille |e verfasserin |4 aut | |
700 | 1 | |a Boesgaard Norsk, Jakob |e verfasserin |4 aut | |
700 | 1 | |a Eiken, Aleksander |e verfasserin |4 aut | |
700 | 1 | |a Andersen, Ove |e verfasserin |4 aut | |
700 | 1 | |a Fischer, Thea Kølsen |e verfasserin |4 aut | |
700 | 1 | |a Juul Jensen, Claus Antonio |e verfasserin |4 aut | |
700 | 1 | |a Torp-Pedersen, Christian |e verfasserin |4 aut | |
700 | 1 | |a Rungby, Jørgen |e verfasserin |4 aut | |
700 | 1 | |a Ditlev, Sisse Bolm |e verfasserin |4 aut | |
700 | 1 | |a Hageman, Ida |e verfasserin |4 aut | |
700 | 1 | |a Møgelvang, Rasmus |e verfasserin |4 aut | |
700 | 1 | |a Gybel-Brask, Mikkel |e verfasserin |4 aut | |
700 | 1 | |a Dessau, Ram Benny |e verfasserin |4 aut | |
700 | 1 | |a Sørensen, Erik |e verfasserin |4 aut | |
700 | 1 | |a Harritshøj, Lene |e verfasserin |4 aut | |
700 | 1 | |a Folke, Fredrik |e verfasserin |4 aut | |
700 | 1 | |a Engel Møller, Maria Elizabeth |e verfasserin |4 aut | |
700 | 1 | |a Benfield, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Ullum, Henrik |e verfasserin |4 aut | |
700 | 1 | |a Sværke Jørgensen, Charlotte |e verfasserin |4 aut | |
700 | 1 | |a Rye Ostrowski, Sisse |e verfasserin |4 aut | |
700 | 1 | |a Dam Nielsen, Susanne |e verfasserin |4 aut | |
700 | 1 | |a Bundgaard, Henning |e verfasserin |4 aut | |
700 | 1 | |a Iversen, Kasper |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of infectious diseases |d 1945 |g 226(2022), 1 vom: 12. Aug., Seite 6-10 |w (DE-627)NLM000005819 |x 1537-6613 |7 nnns |
773 | 1 | 8 | |g volume:226 |g year:2022 |g number:1 |g day:12 |g month:08 |g pages:6-10 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/infdis/jiac001 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 226 |j 2022 |e 1 |b 12 |c 08 |h 6-10 |